174 related articles for article (PubMed ID: 22538218)
1. Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.
Introini U; Casalino G; Querques G; Gimeno AT; Scotti F; Bandello F
Eye (Lond); 2012 Jul; 26(7):976-82. PubMed ID: 22538218
[TBL] [Abstract][Full Text] [Related]
2. Fluorescein angiography and spectral-domain optical coherence tomography for monitoring anti-VEGF therapy in myopic choroidal neovascularization.
Iacono P; Battaglia Parodi M; Papayannis A; Kontadakis S; Da Pozzo S; Cascavilla ML; La Spina C; Varano M; Bandello F
Ophthalmic Res; 2014; 52(1):25-31. PubMed ID: 24861045
[TBL] [Abstract][Full Text] [Related]
3. Fluorescein Leakage and Optical Coherence Tomography Features of Choroidal Neovascularization Secondary to Pathologic Myopia.
Battaglia Parodi M; Iacono P; Romano F; Bandello F
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3175-3180. PubMed ID: 30025121
[TBL] [Abstract][Full Text] [Related]
4. Spectral-Domain Optical Coherence Tomography of Subretinal Hyperreflective Exudation in Myopic Choroidal Neovascularization.
Bruyère E; Caillaux V; Cohen SY; Martiano D; Ores R; Puche N; Souied EH
Am J Ophthalmol; 2015 Oct; 160(4):749-58.e1. PubMed ID: 26164828
[TBL] [Abstract][Full Text] [Related]
5. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
Khurana RN; Dupas B; Bressler NM
Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
[TBL] [Abstract][Full Text] [Related]
6. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
[TBL] [Abstract][Full Text] [Related]
7. [Macular choroidal thickness assessment with SD-OCT in high myopia with or without choroidal neovascularization].
El Matri L; Bouladi M; Chebil A; Kort F; Largueche L; Mghaieth F
J Fr Ophtalmol; 2013 Oct; 36(8):687-92. PubMed ID: 23896210
[TBL] [Abstract][Full Text] [Related]
8. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
9. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
Cheng Y; Li Y; Huang X; Qu Y
Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
[TBL] [Abstract][Full Text] [Related]
10. Fluorescein angiography and optical coherence tomography in myopic choroidal neovascularization.
Chhablani J; Deepa MJ; Tyagi M; Narayanan R; Kozak I
Eye (Lond); 2015 Apr; 29(4):519-24. PubMed ID: 25613842
[TBL] [Abstract][Full Text] [Related]
11. Optical Coherence Tomography Angiography of Inflammatory Choroidal Neovascularization Early Response after Anti-VEGF Treatment.
Tang W; Guo J; Liu W; Xu G
Curr Eye Res; 2020 Dec; 45(12):1556-1562. PubMed ID: 32394732
[No Abstract] [Full Text] [Related]
12. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
Battaglia Parodi M; Iacono P; Bandello F
Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
You JY; Chung H; Kim HC
Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
[TBL] [Abstract][Full Text] [Related]
14. Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography.
Lee DH; Kang HG; Lee SC; Kim M
Br J Ophthalmol; 2018 Feb; 102(2):238-242. PubMed ID: 28600301
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
Ladaique M; Dirani A; Ambresin A
Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
Ruiz-Moreno JM; Montero JA; Gomez-Ulla F; Ares S
Br J Ophthalmol; 2009 Apr; 93(4):448-51. PubMed ID: 19091851
[TBL] [Abstract][Full Text] [Related]
17. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
Ahn SJ; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti-vascular endothelial growth factor.
Lee DY; Wu PY; Sheu SJ
Kaohsiung J Med Sci; 2023 Jun; 39(6):637-643. PubMed ID: 36916244
[TBL] [Abstract][Full Text] [Related]
19. Vascular remodeling of choroidal neovascularization in older myopic patients treated with ranibizumab.
Cohen SY; Tabary S; El Ameen A; Mrejen S; Quentel G; Giocanti-Auregan A
Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):485-493. PubMed ID: 30535969
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular Endothelial Growth Factor Antibody Limits the Vascular Leakage and Decreases Subretinal Fibrosis in a Cynomolgus Monkey Choroidal Neovascularization Model.
Inagaki S; Shimazawa M; Hamaguchi K; Otsu W; Araki T; Sasaki Y; Numata Y; Tsusaki H; Hara H
Curr Neurovasc Res; 2020; 17(4):420-428. PubMed ID: 32445455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
